Quick Answer
ESCALON MEDICAL CORP reported Cash and Equivalents of $545.8 thousand for fiscal year 2025.
ESCALON MEDICAL CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $545.8K | +161.1% |
| 2024 | $209.0K | -76.5% |
| 2023 | $889.7K | +49.8% |
| 2022 | $593.9K | -64.0% |
| 2021 | $1.65M | +99.9% |
| 2020 | $826.0K | +101.6% |
| 2019 | $409.7K | -53.1% |
| 2018 | $874.0K | +60.6% |
| 2017 | $544.1K | +1.1% |
| 2016 | $538.1K | -64.5% |
| 2015 | $1.52M | -24.5% |
| 2014 | $2.01M | +273.4% |
| 2013 | $538.1K | -39.6% |
| 2012 | $890.6K | -41.2% |
| 2011 | $1.51M | -46.4% |
| 2010 | $2.82M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $337.4K | -35.2% | -45.2% |
| September 30, 2025 | $615.8K | +168.1% | +12.8% |
| June 30, 2025 | $545.8K | +161.1% | +4.9% |
| December 31, 2024 | $520.6K | +33.3% | +126.6% |
| September 30, 2024 | $229.7K | -69.2% | +9.9% |
| June 30, 2024 | $209.0K | -76.5% | -63.0% |
| March 31, 2024 | $564.7K | +3.7% | +44.6% |
| December 31, 2023 | $390.4K | +24.5% | -47.6% |
- ESCALON MEDICAL CORP showed an increase of +161.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, ESCALON MEDICAL CORP’s cash and equivalents has declined by 80.7% (from $2.82 million to $545.8 thousand).
- The most recent figure is from ESCALON MEDICAL CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: